Habermann et al. specifically investigated the role of dietary n-3 LC-PUFA in subjects with genetic variants known to increase PG-derived inflammatory markers (i.e., PTGS1 and PTGS2, genes of PG synthesis enzymes), and found inverse associations between CRC risk and increased intake of EPA or DHA. The gene discussed is PTGS1; the disease is colorectal carcinoma.